Richard K Burt

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

Hematopoietic Stem Cell

Randomized Controlled Trial

Systemic Sclerosis

Top Venues

Bone marrow transplantation

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Richard K Burt, Paolo Antonio Muraro, Dominique Farge, Maria Carolina Oliveira, John A Snowden, Riccardo Saccardi, Xiaoqiang Han, Kathleen Quigley, Valquiria Bueno, Daniela Frasca, Denis Fedorenko, Joachim Burman
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone marrow transplantation 56 (7) (2021)
Richard K Burt, Xiaoqiang Han, Kathleen Quigley, Irene B Helenowski, Roumen Balabanov
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis. Journal of neurology (2021)
Nassim Ait Abdallah, Mianbo Wang, Pauline Lansiaux, Mathieu Puyade, Sabine Berthier, Louis Terriou, Catney Charles, Richard K Burt, Marie Hudson, Dominique Farge
Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score. Bone marrow transplantation 56 (9) (2021)
Richard K Burt, Roumen Balabanov, Jinny Tavee, Xiaoqiang Han, Robert Sufit, Senda Ajroud-Driss, Borko Jovanovic, Kathleen Quigley, Indira Arnautovic, Irene Helenowski, Basil Sharrack
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy. Journal of neurology 267 (11) (2020)
Richard K Burt, Robert Craig, Laura Yun, Amy Halverson, Kathleen Quigley, Indira Arnautovic, Xiaoqiang Han
A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease. Bone marrow transplantation 55 (12) (2020)
Richard K Burt, Xiaoqiang Han, Kathleen Quigley, Indira Arnautovic, Sanjiv J Shah, Daniel C Lee, Benjamin H Freed, Borko Jovanovic, Irene B Helenowski
Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days. Bone marrow transplantation 56 (1) (2020)